Pharmabiz12m
Pfizer’s RSV vaccine Abrysvo receives European approval to help protect adults aged 18-59 against RSV lower respiratory tract disease
Pfizer Inc. announced that the European Commission (EC) has issued a decision amending the marketing authorization for Abrysvo, the company’s bivalent respiratory syncytial virus (RSV) prefusion F ...
Pharmabiz1h
Guidelines issued by Odisha DI are provisions of D&C Act, companies cannot fully comply with it: Ex TN DC
Peethaambaran Kunnathoor, Chennai Wednesday, April 2, 2025, 08:00 Hrs [IST] ...
Pharmabiz1h
Panel asks DoP to prepare comprehensive action plan to enhance infrastructure in seven existing NIPERs
Panel asks DoP to prepare comprehensive action plan to enhance infrastructure in seven existing NIPERs: Gireesh Babu, New Delhi Wednesday, April 2, 2025, 08:00 Hrs [IST] Raising c ...
Pharmabiz1h
Gujarat FDCA to strengthen drug quality control with procurement of 25 advanced handheld spectrophotometers
Gujarat FDCA to strengthen drug quality control with procurement of 25 advanced handheld spectrophotometers: Shardul Nautiyal, Mumbai Wednesday, April 2, 2025, 08:00 Hrs [IST] In ...
Pharmabiz1h
Dr Sanjay Agrawal applies for patent for a specialized formulation for CKD related nutritional deficiencies
Dr Sanjay Agrawal applies for patent for a specialized formulation for CKD related nutritional deficiencies: Shardul Nautiyal, Mumbai Wednesday, April 2, 2025, 08:00 Hrs [IST] Dr ...
Pharmabiz1h
Karnataka & Netherlands accelerate pace of AI driven healthtech implementation across govt hospitals
Karnataka & Netherlands accelerate pace of AI driven healthtech implementation across govt hospitals: Nandita Vijayasimha, Bengaluru Wednesday, April 2, 2025, 08:00 Hrs [IST] Karn ...
Pharmabiz17h
Heartnet India’s Hridaya initiative strengthens women’s cardiac care in Moyna
Heartnet India’s Hridaya initiative strengthens women’s cardiac care in Moyna: Our Bureau, Bengaluru Tuesday, April 1, 2025, 15:30 Hrs [IST] Heartnet India, an IoT-driven card ...
Pharmabiz16h
EMA committee recommends approval of AstraZeneca’s Calquence plus chemoimmunotherapy to treat adult patients with mantle cell lymphoma
EMA committee recommends approval of AstraZeneca’s Calquence plus chemoimmunotherapy to treat adult patients with mantle cell lymphoma: Cambridge, UK Tuesday, April 1, 2025, 17: ...
Pharmabiz17h
Poly Medicure inks pact with AMPIN Energy Transition for 10MWp solar project in Haryana
Poly Medicure inks pact with AMPIN Energy Transition for 10MWp solar project in Haryana: Our Bureau, Bengaluru Tuesday, April 1, 2025, 15:50 Hrs [IST] Poly Medicure Ltd., a leadin ...
Pharmabiz18h
China NMPA grants breakthrough therapy designation for Innovent’s PD-1/IL-2a-bias bispecific antibody fusion protein, IBI363 in melanoma
San Francisco, US Tuesday, April 1, 2025, 15:00 Hrs [IST] ...
Pharmabiz17h
Valneva submits label extension application for Ixchiq with UK MHRA to expand its use to adolescents aged 12 to 17 years in EU
Saint Herblain, France Tuesday, April 1, 2025, 16:00 Hrs [IST] ...
Pharmabiz17h
HOSMAC to lead turnkey design consultancy for central India’s premier eye care centre
HOSMAC to lead turnkey design consultancy for central India’s premier eye care centre: Our Bureau, Bengaluru Tuesday, April 1, 2025, 15:40 Hrs [IST] HOSMAC, Asia’s leading hos ...